Saverio G Parisi

Author PubWeight™ 15.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data. AIDS 2011 2.11
2 Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. J Antimicrob Chemother 2009 1.43
3 Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. J Med Virol 2003 1.36
4 Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002 1.13
5 Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS. J Acquir Immune Defic Syndr 2006 0.92
6 Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. J Clin Microbiol 2003 0.90
7 Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells. J Clin Microbiol 2002 0.87
8 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV. Cochrane Database Syst Rev 2013 0.82
9 High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis. J Clin Microbiol 2003 0.81
10 Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients. AIDS 2005 0.81
11 Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy. AIDS Res Hum Retroviruses 2004 0.79
12 Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period. Transfusion 2003 0.79
13 Drug-resistance mutations can be archived very early in HIV primary infection. AIDS 2006 0.78
14 Rome Consensus Conference - statement; human papilloma virus diseases in males. BMC Public Health 2013 0.77
15 Viral growth assay to evaluate the replicative capacity of HIV-1 isolates. J Virol Methods 2004 0.76
16 Human immunodeficiency virus polymorphisms and zidovudine resistance. Antimicrob Agents Chemother 2003 0.75
17 Deep neck abscess due to Acinetobacter baumannii infection. Am J Otolaryngol 2009 0.75